Most cancer-related studies have focused on the role of somatic alternations in SAMHD1 [37]; however, a study of chronic lymphoid leukemia (CLL) proposed an oncogenic role of germline SAMHD1 variation mediated by DNA repair mechanisms [38]. This evidence concerns the gene SAMHD1 and B-cell chronic lymphocytic leukemia.